Progress of RAGE Molecular Imaging in Alzheimer's Disease.
AD
PET
RAGE
[18F]-FPS-ZM1
neurofibrillary tangles
senile plaques
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
03
2020
accepted:
29
06
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by senile plaques (SPs), which are caused by amyloid beta (Aβ) deposition and neurofibrillary tangles (NFTs) of abnormal hyperphosphorylated tau protein. The receptor for advanced glycation end products (RAGE) binds to advanced glycation end products deposited during vascular dysfunction. Alzheimer's disease may occur when RAGE binds to Aβ and releases reactive oxygen species, further exacerbating Aβ deposition and eventually leading to SPs and NFTs. As it is involved in early AD, RAGE may be considered as a more potent biomarker than Aβ. Positron emission tomography provides valuable information regarding the underlying pathological processes of AD many years before the appearance of clinical symptoms. Thus, to further reveal the role of RAGE in AD pathology and for early diagnosis of AD, a tracer that targets RAGE is needed. In this review, we first describe the early diagnosis of AD and then summarize the interaction between RAGE and Aβ and Tau that is required to induce AD pathology, and finally focus on RAGE-targeting probes, highlighting the potential of RAGE to be used as an effective target. The development of RAGE probes is expected to aid in AD diagnosis and treatment.
Identifiants
pubmed: 32848706
doi: 10.3389/fnagi.2020.00227
pmc: PMC7417350
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
227Informations de copyright
Copyright © 2020 Kong, Liu, Zhou, Qi, Zhang, Sun, Wang and Guan.
Références
Neurobiol Aging. 2012 Jan;33(1):196.e13-27
pubmed: 20638753
Protein Expr Purif. 2008 Feb;57(2):143-52
pubmed: 18039581
Cancer Res. 2015 Mar 15;75(6):974-85
pubmed: 25572331
PLoS One. 2019 Jan 31;14(1):e0210621
pubmed: 30703120
Neurology. 2007 Apr 10;68(15):1205-12
pubmed: 17420404
Recent Adv Cardiovasc Drug Discov. 2015;10(1):10-33
pubmed: 26530458
Nature. 1996 Aug 22;382(6593):685-91
pubmed: 8751438
Neurosci Biobehav Rev. 2016 Mar;62:48-55
pubmed: 26724598
J Neurol Sci. 2012 Jun 15;317(1-2):1-5
pubmed: 22410257
Int J Mol Sci. 2019 Jan 17;20(2):
pubmed: 30658419
Exp Mol Med. 2014 Feb 07;46:e75
pubmed: 24503708
Lancet Neurol. 2018 Apr;17(4):335-346
pubmed: 29500152
FASEB J. 2008 May;22(5):1572-80
pubmed: 18089847
Neurology. 2014 Apr 29;82(17):1536-42
pubmed: 24696507
Cell Mol Neurobiol. 2016 May;36(4):483-95
pubmed: 26175217
J Nucl Med. 2010 Jan;51(1):92-7
pubmed: 20008983
Am J Transl Res. 2017 Feb 15;9(2):247-260
pubmed: 28337257
Structure. 2011 May 11;19(5):722-32
pubmed: 21565706
Biochim Biophys Acta. 2016 May;1862(5):887-900
pubmed: 26705676
Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2189-2202
pubmed: 31047972
Neurobiol Aging. 2011 May;32(5):763-77
pubmed: 19464758
J Mol Med (Berl). 2005 Nov;83(11):876-86
pubmed: 16133426
Antioxid Redox Signal. 2012 Jun 15;16(12):1369-83
pubmed: 22248368
Mol Neurodegener. 2017 Feb 20;12(1):19
pubmed: 28219440
J Neurochem. 2015 Jul;134(2):382-93
pubmed: 25866188
Neurobiol Aging. 2012 Jul;33(7):1400-10
pubmed: 21450369
Curr Pharm Des. 2008;14(16):1601-5
pubmed: 18673201
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Cell Tissue Res. 2006 Mar;323(3):475-88
pubmed: 16315007
Neurobiol Aging. 2014 Jun;35(6):1301-8
pubmed: 24484607
Amino Acids. 2011 Oct;41(4):809-20
pubmed: 21153848
Hum Mol Genet. 2018 Mar 15;27(6):1002-1014
pubmed: 29329433
Front Biosci (Elite Ed). 2020 Mar 1;12:150-161
pubmed: 32114455
Science. 2002 Jul 19;297(5580):353-6
pubmed: 12130773
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):451-489
pubmed: 31541283
Front Neurosci. 2018 Sep 27;12:681
pubmed: 30319347
Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1052-61
pubmed: 25792456
J Cereb Blood Flow Metab. 2015 Mar;35(3):359-62
pubmed: 25515210
PLoS One. 2019 Dec 12;14(12):e0226368
pubmed: 31830091
Int J Neurosci. 2014 Aug;124(8):601-8
pubmed: 24228859
Methods Mol Biol. 2018;1781:287-307
pubmed: 29705853
Future Med Chem. 2012 May;4(7):915-25
pubmed: 22571615
FASEB J. 2010 Apr;24(4):1043-55
pubmed: 19906677
Nat Med. 2003 Jul;9(7):907-13
pubmed: 12808450
Acta Neuropathol Commun. 2015 Jul 02;3:40
pubmed: 26134112
Theranostics. 2018 Oct 5;8(18):5012-5024
pubmed: 30429883
Neurobiol Aging. 2012 May;33(5):1006.e11-23
pubmed: 22048125
J Clin Invest. 2012 Apr;122(4):1377-92
pubmed: 22406537
Ageing Res Rev. 2017 Mar;34:77-87
pubmed: 27697546
Cells. 2020 Feb 07;9(2):
pubmed: 32046119
Neuropharmacology. 2015 Feb;89:175-84
pubmed: 25261783
J Alzheimers Dis. 2019;71(1):291-305
pubmed: 31381511
Brain. 2017 Mar 1;140(3):781-791
pubmed: 28122879
J Neurochem. 2003 Oct;87(1):44-55
pubmed: 12969251
BMC Neurol. 2018 Aug 8;18(1):109
pubmed: 30089453
J Clin Invest. 2018 Feb 1;128(2):682-698
pubmed: 29337308
Respir Res. 2019 Jun 10;20(1):116
pubmed: 31182072
Q J Nucl Med Mol Imaging. 2017 Dec;61(4):405-413
pubmed: 28750496
Cancer Genet. 2011 Sep;204(9):486-91
pubmed: 22018270
Alzheimers Dement. 2018 Sep;14(9):1171-1183
pubmed: 29907423
Curr Alzheimer Res. 2007 Apr;4(2):191-7
pubmed: 17430246
Neurochem Res. 2016 May;41(5):1192-9
pubmed: 26738988
Curr Alzheimer Res. 2014;11(5):430-40
pubmed: 24801214
Eur J Med Chem. 2014 May 22;79:128-42
pubmed: 24727489
Sci Rep. 2016 Apr 06;6:23964
pubmed: 27050297
Ann Nucl Med. 2018 Nov;32(9):583-593
pubmed: 30128693
Future Med Chem. 2020 Mar;12(6):511-521
pubmed: 32100545
ACS Chem Neurosci. 2016 Mar 16;7(3):391-8
pubmed: 26771209
Biochem Biophys Res Commun. 2013 Sep 20;439(2):252-7
pubmed: 23973487
J Transl Med. 2009 Mar 17;7:17
pubmed: 19292913
PET Clin. 2017 Jul;12(3):329-350
pubmed: 28576171
Neurol Sci. 2015 May;36(5):707-12
pubmed: 25452168
PLoS One. 2018 Mar 12;13(3):e0192821
pubmed: 29529089
J Med Chem. 2017 Sep 14;60(17):7213-7232
pubmed: 28482155
Brain. 2014 Jan;137(Pt 1):221-31
pubmed: 24176981
J Surg Oncol. 2018 Aug;118(2):362-373
pubmed: 29938396
Acta Neuropathol. 2009 Sep;118(3):381-9
pubmed: 19277685